Truvant has acquired New Jersey-based Multi-Pak Packaging, adding substantial bottling, blister packaging and controlled-environment capabilities to its contract packaging network.

The Truvant Multi-Pak acquisition, announced on August 25, strengthens Truvant’s position in vitamins, minerals and supplements, over-the-counter medicines and consumer health products while also adding capabilities serving beauty, personal care and Class 1 medical devices. Financial terms were not included in Truvant’s announcement.

Multi-Pak will continue operating from its West Caldwell, New Jersey facility as part of Truvant.

For packaging customers, however, the more important part of the transaction is not simply another production site.

It is the type of capacity Truvant is adding.

Multi-Pak Adds More Than 250 Million Bottles of Annual Capacity

Multi-Pak operates more than 180,000 square feet of climate-controlled packaging space in West Caldwell.

Its primary packaging operations include capacity for more than 250 million bottles per year and more than 500 million blisters annually for tablets, caplets and softgels.

The business also handles pouches and sachets and provides secondary packaging services including cartoning, kitting, display assembly and custom assembly.

Those numbers give the acquisition a different character from adding a general-purpose contract packing operation.

Truvant is gaining high-volume packaging infrastructure already configured around products where process control, documentation and quality systems are especially important.

That could allow the company to support a broader portion of a healthcare brand’s packaging requirements within the same contract manufacturing and packaging network.

Probiotic Packaging Brings Another Type of Capability

One of Multi-Pak’s more specialized assets is its dedicated probiotic packaging center.

According to the company, the center includes three controlled packaging suites and warehouse space designed to maintain temperatures below 70°F and relative humidity below 30%.

The operation uses dedicated HVAC, dehumidification, air filtration and continuous environmental monitoring.

Available formats include cold-form blister packaging, vial and bottle filling, and sachet packaging.

That capability deserves attention because probiotics create different packaging requirements from many conventional dry consumer products.

Temperature, moisture and oxygen exposure can affect product stability, meaning packaging operations must consider more than filling speed or pack appearance.

For Truvant, acquiring an established operation with the necessary controlled environment, procedures and equipment provides access to a more specialized section of the health and wellness packaging market.

The Deal Also Expands Truvant’s Regulatory Packaging Base

Multi-Pak is FDA registered and inspected and states that its facility operates in compliance with current Good Manufacturing Practice requirements under 21 CFR Parts 210 and 211.

The company also holds NSF, Organic, Gluten Free and Kosher certifications. Its quality systems include process validation, equipment qualification, component traceability, CAPA procedures, change controls, vendor audits and mock recalls.

This is particularly relevant when looking at the acquisition from a contract packaging perspective.

In consumer packaging, adding another filling or cartoning line can increase capacity.

In regulated healthcare packaging, additional equipment alone is not enough.

The operating procedures, documentation systems, staff training, validated processes and quality infrastructure surrounding those lines are part of the capability being acquired.

That makes Multi-Pak’s existing regulatory framework an important part of the transaction.

Truvant Moves Further Into Health and Wellness Packaging

Truvant currently operates six campuses across North America and Europe and provides contract manufacturing and packaging services across healthcare, beauty and personal care, food and beverage, household products and other consumer categories.

The company said the Multi-Pak acquisition expands its presence in a strategic growth category supported by increasing demand for vitamins, supplements and health products.

Multi-Pak already serves solid-dose OTC, nutritional supplement, consumer health and medical-device customers and was founded in 2005 by John and Debbie Culligan.

For Truvant, this means the deal brings both additional customers and manufacturing capabilities into its wider network.

CEO Stew Atkinson said Multi-Pak expands the company’s capabilities in health-related end markets while complementing Truvant’s existing operations.

Multi-Pak founder John Culligan said joining a larger network would provide additional scale and resources while allowing the New Jersey operation to continue serving existing customers.

Primary and Secondary Packaging Are Becoming More Closely Connected

Another part of the acquisition worth watching is the combination of primary packaging with downstream finishing and supply-chain services.

Multi-Pak can fill bottles, produce blister packs and package sachets, but it also performs cartoning, kitting and display assembly and provides sourcing, procurement, warehousing and distribution support.

That creates the possibility of handling more stages between bulk product and retail-ready goods within one contract packaging relationship.

For brand owners, fewer transfers between separate suppliers can simplify coordination, although the actual commercial benefit will depend on individual product programs and manufacturing arrangements.

For co-packers, however, the direction is clear.

Customers increasingly evaluate contract packaging businesses not only by the number of available machines, but by how many functions they can reliably manage around those machines.

That can include material procurement, primary packaging, secondary packaging, quality control, warehousing and final retail preparation.

Packaging Format Diversity Is Another Part of the Strategy

The transaction also expands Truvant’s exposure to several packaging formats used across healthcare products.

Bottles remain common for supplements and tablets, while blisters provide unit-dose protection and can support product presentation and dosing convenience.

Sachets and pouches serve powders and other single-use or portioned products, while secondary cartons continue to play an important role in product information, branding and retail handling.

Multi-Pak’s operations therefore bring Truvant deeper into both rigid and flexible packaging formats rather than concentrating the acquisition around one package type.

For packaging suppliers, that breadth is relevant.

A larger health and wellness contract packaging platform can influence demand for bottles, closures, blister films and foils, flexible laminates, labels, folding cartons, corrugated cases and other packaging components.

The transaction does not tell us how procurement volumes will change, and Truvant has not published that information.

But the expanded packaging mix is worth following as Multi-Pak is integrated into the wider group.

What Makes This Acquisition Significant?

There are three parts of the deal that stand out from an industry perspective.

First is scale: more than 250 million bottles and 500 million blisters of annual capacity.

Second is specialization: the probiotic operation introduces controlled temperature and humidity requirements alongside conventional packaging processes.

Third is regulatory capability: Multi-Pak already operates within quality systems designed for OTC and healthcare products.

Together, those capabilities give Truvant a stronger entry point into packaging categories where technical requirements and compliance can create higher barriers to entry than conventional secondary contract packing.

The acquisition also reflects a broader question facing contract packaging companies:

Is future growth primarily about adding more production lines, or about adding capabilities that allow one supplier to manage more complex products and more stages of the packaging process?

In this case, Truvant appears to be pursuing the second route.

The New Jersey site will remain operational, so the next issue to watch will be how Truvant connects Multi-Pak’s healthcare capabilities with its wider North American and European network — particularly whether customers begin using the combined group for larger, multi-format packaging programs.

Last Updated on 01/09/2026 by Jota Machinery